Courses & Units
Clinical Pharmacokinetics 4 CSA414
Hobart
Introduction
A study of the clinical pharmacokinetics of individual drugs and groups of drugs, sources of inter-patient variability in pharmacokinetics and the application of pharmacokinetics in practice. As with Clinical Pharmacokinetics 3, particular emphasis is placed on the role of the pharmacist in improving the use of drugs through the practical application of pharmacokinetics and therapeutic drug monitoring. There is extensive use of clinically-oriented problems and cases.
Topics include therapeutic drug monitoring; drug interactions; an overview of sources of inter-patient variability in pharmacokinetics (eg extremes of age, renal or hepatic disease, pharmacogenomics); clinical case studies and pharmacokinetics of specific drugs.
Unit objective: to develop the ability to contribute to improved drug use through the appropriate use of pharmacokinetic techniques and therapeutic drug monitoring.
Summary
Unit name | Clinical Pharmacokinetics 4 |
---|---|
Unit code | CSA414 |
Credit points | 12.5 |
College/School | College of Health and Medicine School of Pharmacy and Pharmacology |
Discipline | Pharmacy |
Coordinator | Doctor Barbara Wimmer |
Delivered By | Delivered wholly by the provider |
Level | Advanced |
Availability
This unit is currently unavailable.
Key Dates
Study Period | Start date | Census date | WW date | End date |
---|---|---|---|---|
Semester 1 | 22/2/2021 | 23/3/2021 | 12/4/2021 | 30/5/2021 |
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2021 are indicative and subject to change. Finalised census dates for 2021 will be available from the 1st October 2020. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Apply pharmaceutical science knowledge (including pharmaceutical calculations) and/or pharmacokinetic principles to solve clinical problems that may contribute to improved quality use of medicines.
- Describe / evaluate / resolve drug interactions, and common side effects of major drug classes in the context of pharmacy practice.
- Provide accurate and appropriate health and medicines advice to a range of consumers (including other health professionals)
- Search, evaluate and appropriately reference drug information and pharmacy related literature
Fee Information
Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
---|---|---|---|---|
060501 | $993.00 | $993.00 | not applicable | $2,354.00 |
- Available as a Commonwealth Supported Place
- HECS-HELP is available on this unit, depending on your eligibility3
- FEE-HELP is available on this unit, depending on your eligibility4
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Prerequisites
CSA311 AND All Year 2 BPharm UnitsTeaching
Teaching Pattern | Online learning resources (equivalent to 2 hours of activity per week) and1 x 2hr workshop weekly. |
---|---|
Assessment | In-class tests (10%)|Exam (65%)|Visual presentation (10%)|Paired written assignment (15%) |
Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
Required |
Required readings will be listed in the unit outline prior to the start of classes. |
Links | Booktopia textbook finder |
---|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.